First infection-fighting monoclonal antibodies scrutinized by FDA Advisory Committee members.
Marwick
C
C
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006090:Gram-Negative Bacteria / Q000276:immunology*; D016905:Gram-Negative Bacterial Infections / Q000628:therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal